Nutrition and HIV in the international setting

Nutrition in Clinical Care

Volumn 8, Issue 1, 2005, Pages 44-48

  Wanke, Christine ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Breast feeding; Global epidemiology; HIV AIDS; Malnutrition; Mother to child transmission

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; NEVIRAPINE; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; TRIACYLGLYCEROL;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; AFRICA; ASIA; BREAST FEEDING; DIARRHEA; DISEASE COURSE; GLUCOSE INTOLERANCE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INSULIN RESISTANCE; MALNUTRITION; MORTALITY; NUTRITION; OPPORTUNISTIC INFECTION; PREVALENCE; PUBLIC HEALTH; REVIEW; VIRUS TRANSMISSION; AIDS RELATED COMPLEX; NUTRITIONAL STATUS;

HUMAN IMMUNODEFICIENCY VIRUS;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; HIV INFECTIONS; HUMANS; MALNUTRITION; NUTRITIONAL STATUS;

EID: 24044462678     PISSN: 10966781     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. Dworkin MS, Williamson JM; Adult/Adolescent Spectrum of HIV Disease Project. AIDS wasting syndrome: trends, influence on opportunistic infections, and survival. J Acquir Immune Defic Syndr. 2003;33: 267-273.
2. Palella FJ Jr, Deloria-Knoll M, Chmiel JS, et al. Survival benefit of initiating antiretroviral therapy in HIV-infected persons in different CD4+ cell strata. Ann Int Med. 2003;138:620-626.
3. Carr A, Samaras K, Thorisdottir A, Kaufmann GR, Chisholm DJ, Cooper DA. Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study. Lancet. 1999;353:2093-2099.
4. Wanke CA, Suva M, Forrester J, Speigelman D, Gorbach SL. Weight loss and wasting remain common complications in individuals infected with HIV in the era of highly active antiretroviral therapy. Clin Infect Dis. 2000;31:803-805.
5. World Health Organization. AIDS epidemic update, December 2003. Available at: http://www.unaids.org/html/pub/publications/irc-pub06/jc943-epiupdate2003_ en_pdf.htm. Accessed February 18, 2005.
6. Laurent C, Kouanfack S, Koulla-Shiro S, et al. Effectiveness and safety of a generic fixed dose combination of neveripine, stavudine, and lamivudine in HIV-1-infected adults in Cameroon: open-label multicentre trial. Lancet. 2004;364:29-34.
7. Wheeler DA, Gibert CL, Launer CA, et al. Weight loss as a predictor of survival and disease progression in HIV infection. Terry Beirn Community Programs for Clinical Research on AIDS. J Acquir Immune Defic Synd Hum Retrovirol. 1998;18:80-85.
8. Guenter P, Muurahainen N, Simons G, et al. Relationships among nutritional status, disease progression, and survival in HIV infection. J Acquir Immune Defic Syndr. 1993;6:1130-1138.
9. Tang AM, Forrester J, Spiegelman D, Knox TA, Tchetgen E, Gorbach SL. Weight loss and survival in HIV-positive patients in the era of highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2002;31: 230-236.
10. Sanghyam S, Kumaraswamy, Solomon S, Anitha C, Mayer K, Flanigan T, Wanke CA. Weight and body shape changes associated with ART in South India. Paper presented at: 11th Conference on Retroviruses and Infection; February 8-11, 2004; San Francisco, CA.
11. Semba RD, Tang AM. Micronutrients and the pathogenesis of human immunodeficiency virus infection. Br J Nutr. 1999;81:181-189.
12. Fawzi W. Micronutrients and human immunodeficiency virus-1 disease progression among adults and children. Clin Infect Dis. 2003;37(suppl 2):S112-S116.
13. Jiamton S, Pepin J, Suttent R, et al. A randomized trial of the impact of multiple micronutrient supplementation on mortality among HIV-infected individuals living in Bangkok. AIDS. 2003;17:2461-2469.
14. Harries AD, Hargreaves NJ, Kemp J, et al. Deaths from tuberculosis in sub-Saharan African countries with a high prevalence of HIV-1. Lancet. 2001;357:1519-1523.
15. Lew EA, Poles MA, Dieterich DT. Diarrheal diseases associated with HIV infection. Gastroenterol Clin North Am. 1997;26:259-290.
16. Lima AA, Fang G, Schorling JB, et al. Persistent diarrhea in northeast Brazil: etiologies and interactions with malnutrition. Acta Paediatr. 1992;381:39-44.
17. Caulfield LE, de Onis M, Blossner M, Black RE. Undernutrition as an underlying cause of child deaths associated with diarrhea, pneumonia, malaria, and measles. Am J Clin Nutr. 2004;80:193-198.
18. Navin TR, Weber R, Vugia DJ, et al. Declining CD4+ T-lymphocyte counts are associated with increased risk of enteric parasitosis and chronic diarrhea: results of a 3-year longitudinal study. J Acquir Immune Defic Syndr Hum Retrovirol. 1999;20:154-159.
19. Brantley RK, Williams KR, Silva TM, et al. AIDS-associated diarrhea and wasting in Northeast Brazil is associated with subtherapeutic plasma levels of antiretroviral medications and with both bovine and human subtypes of Cryptosporidium parvum. Braz J Infect Dis. 2003;7:16-22.
20. Scarlatti G. Mother-to-child transmission of HIV-1: advances and controversies of the twentieth centuries. AIDS Rev. 2004;6:67-78.
21. Fawzi WW, Msamanga GI, Speigelman D, et al. A randomized trial of multivitamin supplements and HIV disease progression and mortality. N Engl J Med. 2004; 351:23-32.
22. Fawzi WW, Msamanga GI, Hunter D, et al. Randomized trial of vitamin supplements in relation to transmission of HIV-1 through breastfeeding and early child mortality. AIDS. 2002;16:1935-1944.
23. Heymann SJ, Vo P. The breast-feeding dilemma and its impact on HIV-infected women and their children. AIDS Read. 1999;9:292-299.
24. Mwamburi DM, Wilson IB, Jacobson DL, et al. Understanding the role of HIV load in determining weight change in the era of highly active antiretroviral therapy. Clin Infect Dis. 2005;40:l67-173.
25. Noor MA, Seneviratne T, Aweeka FT, et al. Indinavir acutely inhibits insulin-stimulated glucose disposal in humans: a randomized, placebo-controlled study. AIDS. 2002;16:F1-F8.
26. Grunfeld C, Kotler D, Shigenaga J, et al. Circulating interferon-alpha levels and hypertriglyceridemia in the acquired immunodeficiency syndrome. Am J Med. 1991;90:154-162.
27. Purnell JQ, Zambon A, Knopp RH, et al. Effects of ritonavir on lipids and post-heparin lipase activities in normal subjects. AIDS. 2000;l4:51-57.
28. van Leth F, Phanuphak P, Ruxrungtham K, et al. Comparison of first-line antiretroviral therapy with regimens including neviripine, efavirenz, or both drugs, plus stavudine and lamivudine: an randomised, open-label trial, the 2NN Study. Lancet. 2004;363:1253-1263.
29. World Health Organization. Scaling up Antiretroviral Therapy in Resource-Limited Settings: Treatment Guidelines for a Public Health Approach. 2003 revision. Available at: http://www.who.int/3by5/ publications/documents/ arv_guidelines/en/. Accessed February 18, 2005.
30. McKeigue PM, Ferrie JE, Pierpoint T, Marmot MG. Association of early-onset coronary heart disease in South Asian men with glucose intolerance and hyperinsulinemia. Circulation. 1993;87:152-161.
31. Reddy KS. Cardiovascular disease and diabetes in migrants: interaction between nutritional changes and genetic background. In: Shetty PS, McPherson K, eds. Diet, Nutrition and Chronic Disease: Lessons From Contrasting Worlds. Chichester, UK: Wiley; 1997:71-75.